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A specific defect of mice lacking cyclin D1 (Cyl-12/2) is impaired development of the mammary gland during pregnancy.
ere we show that when tissue from Cyl-12/2 mammary gland was transplanted into empty mammary fat pad of wild-type
mice, the abnormal phenotype was maintained, indicating that it is epithelial cell autonomous. Nevertheless, in pregnancy
the early proliferative response, which is characterized by extensive side branching, still occurs in the absence of cyclin D1.
However, the response is atypical due to a marked reduction in the formation of accompanying alveoli. This reduction and
delay in alveolar development persists throughout pregnancy. Moreover, although prolactin synthesis and release appear to
be normal, lactogenesis is severely compromised. Consistent with the appearance of numerous side branches, progesterone
receptor expression was readily detected in the mammary tissue of pregnant Cyl-12/2 mice, although there was a significant
hange in the ratio of the two (A and B) receptor isoforms. In Cyl-12/2 mammary glands during late pregnancy there was a
decrease in the abundance of total and phosphorylated Stat5a, as well as delayed onset and substantial diminution of milk
protein expression. The biochemical analysis suggests that there is a cumulative delay in growth and differentiation of the
mammary gland during pregnancy that results in a severely compromised gland when, at parturition, further development
is curtailed by the abrupt change in hormonal milieu. © 1999 Academic Presso
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The decision of a cell to divide involves the integration of
a complex network of signals involving extracellular
growth factors as well as cell:cell and cell:matrix interac-
tions. A central role is played by the activity of the cyclin
D-dependent kinases, which appear to function at the
interface between transduced signals and the cell cycle
machinery (reviewed in Sherr, 1996). Cyclin D1 and the
other family members D2 and D3 are widely expressed
regulatory subunits of the cyclin-dependent kinases (CDKs)
that control progression through the G1 phase of the
mammalian cell division cycle. The three D-type cyclins
are structurally related and each can form complexes with
CDK4 and CDK6, two members of this kinase family.
Despite the high degree of biochemical similarity among
the D-type cyclins, the level of functional redundancy is0012-1606/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.nly partially understood. Activation of CDK4 and/or
DK6 early in G1 requires both binding of a D-type cyclin
nd modification of the holoenzyme by phosphorylation
nd dephosphorylation. Additional regulation is provided
y two families of inhibitory proteins that bind specifically
o the CDK subunit or to the kinase complex, preventing
ither its formation or its activation, respectively (reviewed
n Hall and Peters, 1996; Sherr and Roberts, 1995). Com-
itment to cell division correlates temporally with phos-
horylation by the D-type cyclin complexes of the pocket-
rotein family, composed of retinoblastoma protein (Rb),
107, and p130 (Weinberg, 1995). This releases the negative
egulation that the pocket proteins impose upon a number
f transcription factors that are necessary for the synthesis
f several proteins involved in DNA replication. Despite
he apparently crucial nature of cyclin D1 in cell cycle
rogression, mice lacking cyclin D1 (Cyl-12/2) reach sexual1
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2 Fantl et al.maturity, are fertile, and continue to be viable (Fantl et al.,
995; Sicinski et al., 1995). Nevertheless they show distinct
henotypic abnormalities. After birth they grow more
lowly and remain smaller than their wild-type littermates.
hey display a severe retinopathy and fail to suckle their
oung due to impairment of mammary gland development
uring pregnancy and lactation. The importance of cyclin
1 in the mammary gland is further supported by its
levated expression in approximately 40% of human breast
ancers (Bartkova et al., 1994; Gillett et al., 1994). Thus it
ould appear that for its normal functioning the mammary
land is highly dependent on appropriate expression of
yclin D1.
The major morphological changes of the mammary gland
n the postpubertal mouse are orchestrated by the steroid
ormones estrogen and progesterone and the peptide hor-
ones of the pituitary, prolactin and growth hormone.
ecent findings obtained from estrogen and progesterone
eceptor-deficient mice indicate that estrogen acts on the
troma to induce ductal growth while the progesterone
eceptor, which is induced in the epithelium by estrogen, is
ore important for side branching and alveolar morphogen-
sis (Korach et al., 1996; Lyndon et al., 1995). In addition to
heir direct effect on target cells, steroid receptors can
nduce the production of secreted growth factors that are
nvolved in cell to cell signaling. In cell culture there is a
ood correlation between the mitogenic effects of estrogen
s well as growth factors and the activation of cyclin
1-dependent kinase activity (Altucci et al., 1996; Lukas et
l., 1996; Musgrove et al., 1994). More recently further
nsight into a possible mechanism of action of cyclin D1 in
he mammary gland was provided by in vitro observations
hat it can act as a transcriptional coactivator for the
strogen receptor (Neuman et al., 1997; Zwijsen et al.,
997). This possible function of cyclin D1 could explain
hy elevated expression of the protein is strongly corre-
ated with estrogen receptor-positive breast tumors (Bart-
ova et al., 1994; Gillett et al., 1994). Hence, the pheno-
ypic effects of abrogating cyclin D1 in the mammary gland
ay reside not only in its role as an interface between
rowth stimulation signals and the cell cycle machinery,
ut also through its potential as a coactivator for estrogen
eceptor regulated gene expression. Alternatively, it is pos-
ible that the mammary gland phenotype in Cyl-12/2 mice
erives from an endocrine abnormality. Thus a defect in the
nterior pituitary could account for the mammary gland
bnormality as well as the smaller size of the mutant mice
ince both prolactin and growth hormone are among the
everal hormones that are synthesized and secreted by this
issue. To distinguish between these various possibilities,
e have investigated prolactin synthesis and secretion and
xamined the ability of mammary gland epithelium from
yl-12/2 mice to grow in a wild-type stroma. In addition, we
have analyzed mammary tissue from cyclin D1-deficient
mice, for the abundance of a number of gene products that
are temporally regulated during pregnancy, to provide bio-
chemical indicators of its abnormal development.Copyright © 1999 by Academic Press. All rightMETHODS
Histology
For histological examination of pituitary glands and mammary
tissues, samples were fixed in buffered 10% formalin, dehydrated
through a graded alcohol series, embedded in paraffin wax, and
sectioned at 4 mm before being stained with hematoxylin and eosin.
Mammary glands for whole-mount preparations were spread on a
glass slide, fixed in methanol:chloroform:acetic acid (6:3:1), and
stained with alum-carmine red as described in Banerjee et al.
(1976).
RNA Analysis
Fresh pituitaries were collected into ice-cold phosphate-buffered
saline and the tissue was subsequently disrupted in 800 ml of Trizol
Gibco BRL) using a micro-ultrasonic cell disrupter. Total RNA was
repared according to the manufacturer’s instructions and dis-
olved in sterile water (20 ml) and 10 ml was fractionated by
electrophoresis in a formaldehyde–agarose gel. RNA was trans-
ferred to nylon blotting membrane (Electran BDH) and fixed by UV
cross-linking. Hybridization (60°C) and washing of filters (65°C)
were carried out as previously described (Smith et al., 1995). RNA
from mammary glands snap-frozen in liquid nitrogen was similarly
prepared but tissue was disrupted using an Ultra-Turrax T25
homogenizer (Jencons). b-Casein RNA was detected using a cDNA
probe kindly provided by Drs. Jennifer Liao and Jeffrey Rosen,
Baylor College of Medicine, Houston, Texas, and Stat5a using a
cDNA probe kindly provided by Dr. Lothar Hennighausen, NIH,
Bethesda, Maryland.
In Situ Hybridization
This procedure was performed on 5-mm paraffin sections of 4%
araformaldehyde-fixed mouse pituitaries mounted on
-aminopropylethoxysilane-treated slides. The method used here
as been described previously (Steel et al., 1998). Briefly, a rat
rolactin cDNA clone (Gubbins et al., 1980), kindly provided by
. A. Maurer (Oregon Health Sciences University) was used to
repare a digoxigenin-labeled cRNA probe (approximately 350
ases) by in vitro transcription using an Ambion Megascript SP6 kit
AMS Biotechnology) and adding digoxigenin-11–UTP (Boehringer)
o the kit components. Before the probe was applied, tissue sections
ere permeabilized by digestion with 1 mg/ml proteinase K in
phosphate-buffered saline (PBS) with 1 mM EDTA at 37°C for 30
min. For detection of the hybridized probe, slides were incubated
with an anti-digoxigenin-alkaline phosphatase conjugate (Boehr-
inger Mannheim), at 1:500 dilution for 2 h at room temperature.
Alkaline phosphatase-labeled hybrids were detected using nitro
blue tetrazolium (NBT, Sigma), 5-bromo-4-chloro-3-indolyl phos-
phate (BCIP, Sigma), and levamisole. The incubation time was
determined microscopically, but was usually 1–4 h. Slides were
mounted in aqueous mountant (Glycergel, Dako).
Serum Prolactin Levels
Nb2 cells, a rat lymphoma cell line (kindly provided by Dr. Peter
Gout, British Columbia Cancer Agency, Canada) that is extremely
sensitive to prolactin, was used to bioassay prolactin concentra-
tions in mouse serum samples. Briefly, Nb2 cells were routinely
grown in Fischer’s leukemia medium containing 10% fetal bovines of reproduction in any form reserved.
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3Mammary Gland Defect in Cyl-12/2 Mice Is Cell Autonomousserum and 10% horse serum. For assays, the cells were collected
and reseeded at a density of 200,000 cells/ml in serum-free Fisher’s
medium containing ITS1 (Collaborative Research, Bedford, MA).
nown concentrations of oPrl (0–500 pg/ml) or mouse serum
amples (1 or 10 ml) were added and cells were counted in a Coulter
counter after 3 days. Serum prolactin levels were determined from
the standard curve using known amounts of prolactin and were
performed at least three times with duplicate cultures (Ginsburg
and Vonderhaar, 1995).
Mammary Gland Transplantation
The transplantation procedure has been previously described
(DeOme et al., 1959; Edwards et al., 1992, 1996) and the recipient
mice were F1 hybrids between 129 and C57Bl mice, the two strains
that contributed to the generation of the Cyl-12/2 mice. In brief, the
ipple region from both No. 4 mammary fat pads was removed
nder anesthesia from 20- to 24-day-old mice. The remaining
egions of each contralateral fat pad were immediately implanted
ith a piece of donor mammary gland (0.5–1 mm diameter), from
irgin cyclin D1-deficient and heterozygous control mice, respec-
ively. Tissue from a given donor was transplanted into three
ecipient mice and a total of three different Cyl-12/2 donors were
investigated. Transplanted tissue was allowed to grow for 6–12
weeks before mice were mated. At 16.5 or 17.5 days postcoitum,
transplanted No. 4 glands, as well as an unoperated No. 3 gland,
were removed and processed as whole mounts (see below). The
presence of donor epithelium in each transplant was verified by
PCR analysis. The success of the initial fat pad “clearing” was
confirmed by whole mounting the removed nipple region to ensure
that it contained the rudimentary mammary ductal system.
Mouse Mammary Gland Tissue Extracts
The method used was essentially that described by Liu et al.
1996). A minimum of 0.1 g of tissue, corresponding to mammary
land 4, was used for tissue extraction. This required processing
oth glands for some of the samples. The tissue, stored in liquid
itrogen, was roughly chopped before being disrupted in lysis buffer
sing an Ultra-Turrax T25 homogenizer. Ten milliliters of lysis
uffer, 40 mM Tris–HCl, pH 8, 275 mM NaCl, glycerol (20%),
P-40 (2%), 4 mM EDTA, 20 mM NaF, 2 mM Na3VO4, phenyl-
ethylsulfonyl fluoride (40 mg/ml), aprotinin (50 mg/ml), leupeptin
50 mg/ml) was used per gram of tissue. Extracts were cleared by
entrifugation at 12,000g at 4°C for 15 min. Protein concentration
n the supernatant (10 ml) was measured using Micro BCA Reagent
(Pierce Chemical Co.).
Immunoprecipitation and Western Blotting
Tissue extracts corresponding to 500 mg protein in 500 ml lysis
buffer were incubated with 1 ml Stat5a antibody (L-20, Santa Cruz)
t 4°C with rocking (60 min) before Protein A–Sepharose CL4B
eads were added (40 ml, 1:1 slurry; Pharmacia) and continuing
ncubation overnight. Beads were sedimented by centrifugation (15
) and washed twice with lysis buffer and twice with 50 mM, pH
.0, Tris buffer. After separation by SDS–PAGE on a 7% gel,
mmunoprecipitated protein was transferred to nitrocellulose
embrane (Schleicher & Schuell). Phosphorylated Stat5a and total
mmunoprecipitated Stat5a were detected sequentially using a
onoclonal phosphotyrosine antibody (PY99, Santa Cruz) and the
tat5a antibody (detailed above), respectively. The antigens wereCopyright © 1999 by Academic Press. All rightevealed using enhanced chemiluminescence (ECL) according to
he manufacturer’s instructions (Amersham). Additional proteins
ere investigated after SDS–PAGE of 50 or 100 mg total mammary
land extracts using rabbit antisera to progesterone receptor (C-20,
anta Cruz), and whey acidic protein (generously provided by
othar Hennighausen, NIH) and a sheep antiserum to b-casein.
RESULTS
Impaired Growth and Differentiation of Cyl-12/2
Mouse Mammary Glands
To determine the time at which an impairment of mam-
mary gland development is detectable in Cyl-12/2 mice,
hole-mount preparations and stained histological sections
f mammary glands were analyzed from nulliparous mice
nd mice at first pregnancy. Examination of mammary
lands from cyclin D1-deficient and control virgin mice at
ifferent ages showed no clear differences in appearance
Figs. 1A and 1B). However, impaired growth of mammary
issue from Cyl-12/2 mice was discernible at 7.5 day post-
coitum (pc) and quite apparent by 9.5 days pc (Figs. 1C to
1F), becoming more accentuated at late pregnancy and
thereafter (Figs. 1I to 1L). At 9.5 days pc the wild-type and
heterozygous mammary glands had sprouted many new
side branches with club-shaped protuberances characteris-
tic of alveoli (Figs. 1C to 1F). By contrast, although most of
the Cyl-12/2 mammary glands had also developed new
ateral branches, the walls of these ducts were relatively
mooth, denoting sparse alveolar development (Figs. 1E and
F). Moreover, even at later stages, when alveoli were more
bundant on the ducts of cyclin D1-deficient glands, they
ever matched the density of alveoli in comparable wild-
ype glands (Figs. 1 and 2). At parturition, the alveolar
obules of wild-type or heterozygous mammary glands were
ell expanded with milk while those from cyclin D1-
eficient glands were only sparsely filled (Fig. 2). However,
he severity of the phenotype varied among different
yl-12/2 females, ranging from strong to moderate impair-
ment of lobuloalveolar growth, such that milk was some-
times seen in the stomachs of their newborn offspring.
However, even these offspring did not survive beyond the
first day of birth.
Pituitary Glands and Prolactin Synthesis of
Cyl-12/2 Mice Appear Normal
Histological examination of pituitary glands from cyclin
D1-deficient mice showed no apparent abnormalities (data
not shown). Moreover, the level of prolactin mRNA as
assessed by Northern blot analysis confirmed that prolactin
synthesis in the lactogenic cells in this tissue was similar in
Cyl-12/2 and control animals (Fig. 3A). Comparison with
the b-actin controls indicated that there was a small varia-
ion within each group but no significant variation between
he groups. The normal synthesis of prolactin was further
onfirmed by in situ hybridization on a wider spectrum of
ituitary glands (Fig. 3B; and data not shown). No signifi-s of reproduction in any form reserved.
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4 Fantl et al.cant differences were observed between mice heterozygous
or homozygous for Cyl-1 (Fig. 3), whether males, virgin
emales, or pregnant females, although the level of labeling
n all male mice was lower than that in females (data not
hown). To determine whether prolactin was released nor-
ally into the circulatory system, serum levels were also
etermined. The results are summarized in Table 1 and
how very low levels in the serum of virgin females but up
o 10-fold elevation at 1 day postpartum in both mutant and
ontrol mice.
Response of Mammary Gland Epithelium
to Pregnancy
To determine whether the epithelial component of the
Cyl-12/2 mammary gland was able to respond fully to the
FIG. 1. Mammary gland morphology. Whole-mount preparations
nd control mice. Mammary glands were taken at the following ti
ays pc (G and H), 17.5 days pc (I and J), 1 day postpartum (K and L).
(B, D, F, H, J, and L). The bar represents 100 mm.Copyright © 1999 by Academic Press. All rightnormal stromal environment, we transplanted appropriate
pieces of tissue into a wild-type mammary fat pad and
analyzed their response to pregnancy. A comparison of
stained whole-mounted glands from a 17.5-day pc operated
mouse is shown in Fig. 4. Consistently, an impairment of
lobuloalveolar growth was observed in the Cyl-12/2 trans-
plants compared with the contralateral gland transplanted
with control tissue. The extent of growth in the control
transplants was almost indistinguishable from an unoper-
ated gland from the same animal (data not shown). Trans-
plants from several Cyl-12/2 donors were compared with
yl-12/1 transplants in contralateral glands or with unoper-
ted No. 3 glands of the same hosts. In all experiments
yl-12/2 transplants showed a lack of lobuloalveolar growth
characteristic of Cyl-12/2 mice, while heterozygous trans-
lants resembled the unoperated glands of the wild-type
guinal mammary glands comparing development of Cyl-12/2 mice
virgin (A and B), 7.5 days pc (C and D), 9.5 days pc (E and F), 13.5
mary glands from Cyl-12/1 mice (A, C, E, G, I, and K), and Cyl-12/2of in
mes;
Mams of reproduction in any form reserved.
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5Mammary Gland Defect in Cyl-12/2 Mice Is Cell Autonomoushost. Thus the inability of the Cyl-12/2 mammary gland to
respond fully to the stimulus of pregnancy is a cell autono-
mous effect associated with the epithelium.
Markers of Mammary Gland Development in
Cyl-12/2 and Control Mice
To further characterize the impairment of mammary
gland development, the abundance of several biochemical
markers was compared in extracts derived from control and
cyclin D1-deficient mammary glands taken during preg-
nancy and immediately postpartum.
An early effect of pregnancy is an estrogen-mediated
induction of progesterone receptor (PR) in the mammary
epithelium (Haslam, 1988). Although PR is found in both
stroma and epithelium, in the mature gland the epithelium
contains most of the receptor and is estrogen regulated
(Haslam and Shyamala, 1981). Measurement of PR protein
by Western blotting (Fig. 5A) showed that both the A and
the B isoforms of the progesterone receptor were present in
extracts from Cyl-12/2 and control mice. At 11.5, 13.5, and
5.5 days pc there was a distinct elevation of the B isoform
ver the A isoform in the Cyl-12/2 tissue, which by late
pregnancy and at parturition was less apparent. These
FIG. 2. Histological examination of mammary glands from pregna
bottom) showing retarded development (left and center) and poorCopyright © 1999 by Academic Press. All rightndings indicate that although the mammary epithelial
ells from control and Cyl-12/2 mice are responding to
strogen, the response is not identical.
As lobuloalveolar growth advances, more cells in the
ammary gland initiate milk protein synthesis (Robinson
t al., 1995). A key transcription factor involved in the
nduction of several milk proteins is Stat5a (Liu et al., 1997;
akao et al., 1994). In comparison with the abundance of
eratin 19 RNA, a marker of luminal epithelium, in
yl-12/2 mammary glands Stat5a RNA showed three- and
wofold reduction at 17.5 days pc and at 1 day postpartum,
espectively (Fig. 6) (Taylor-Papadimitriou et al., 1991). The
ifference in the level of Stat5a was also reflected by
mmunoblot analysis, which showed more protein in con-
rol samples taken at late pregnancy and after parturition
Fig. 5B). At 11.5 days pc the difference between control and
yl-12/2 tissue was minimal and probably not significant.
Although the level of Stat5a in the mammary gland in-
creases moderately during pregnancy, of more importance
is its activation by phosphorylation, which shows a dra-
matic increase around days 14.5–16.5 days of pregnancy
(Liu et al., 1996). In control tissue there was a similar low
level of Stat5a protein and its activated form at 11.5 and
15.5 days pc, but by 17.5 days pc there was a greatly
ice. Sections at stages indicated were prepared from Cyl-12/2 mice
secretion (right) compared with those from Cyl-12/1 mice (top).nt m
milks of reproduction in any form reserved.
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6 Fantl et al.increased level of phosphorylated Stat5a that was main-
tained in the 1-day postpartum glands (Fig. 5B). Mammary
tissue from Cyl-12/2 mice taken at equivalent times showed
much lower level of Stat5a phosphorylation, although
here was some variability among individual mice. More-
ver, poor morphological development of the mammary
land correlated with low Stat5a activation and poor milk
rotein expression (see below).
FIG. 3. Pituitary prolactin content. Pituitaries of genotypes as in
(top) using b-actin as a control for RNA loading. (Bottom) In situ h
indicated genotype. No significant differences in prolactin levels w
ABLE 1
erum Prolactin Levels in Cyl-12/2 and Control Mice
Genotype Virgin
1 Day
postpartum
yl-12/1 or Cyl-11/1 5.0 (7.4)a n 5 5 50 (16.8) n 5 5
Cyl-12/2 3.3 (5.4) n 5 6 55 (6.5) n 5 4
a Serum prolactin level in ng/ml. The number in parenthesis is
he standard deviation and n is the number of triplicate determi-
nations.Copyright © 1999 by Academic Press. All rightAs markers of lactogenesis, the milk proteins a- and
b-casein and whey acid protein (WAP) were analyzed. These
two types of protein represent early and late milk products,
respectively (Robinson et al., 1995). Northern blot analysis
howed a more than 10-fold reduction of b-casein RNA in
Cyl-12/2 compared to control mice at both day 17.5 of
regnancy and day 1 postpartum (Fig. 6). A more extensive
nalysis by immunoblotting showed that in control mice
he synthesis of a- and b-caseins could just be detected in
he mammary glands by 11.5 days pc, which then showed
n increase up to 17.5 days pc (Fig. 7). In mammary tissue of
yl-12/2 mice, caseins were for the most part barely detect-
able until 15.5 days pc, with levels increasing thereafter but
overall remaining suppressed in comparison with controls.
WAP was not detected in control mammary glands until
17.5 days pc and showed no increase at 1 day postpartum.
By contrast, WAP was not detected in three of four compa-
rable Cyl-12/2 samples (Fig. 7). Consistent with the varia-
ion seen in the morphological analysis, an occasional gland
ttained a higher degree of differentiation. All the analyses
escribed above have used tissue from mice at first preg-
ed were analyzed for prolactin by Northern blotting of total RNA
ization analysis of pituitary glands taken from female mice of the
observed between Cyl-12/2 and Cyl-12/1 mice by either procedure.dicat
ybrid
eres of reproduction in any form reserved.
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7Mammary Gland Defect in Cyl-12/2 Mice Is Cell Autonomousnancy. However, multiple pregnancies did not increase the
ability of mice to suckle their young.
DISCUSSION
Previous studies have shown that in the absence of cyclin
D1 the mammary glands of virgin female mice appear
morphologically normal (Fantl et al., 1995; Sicinski et al.,
1995; and Fig. 1). It is only during their growth and devel-
opment during pregnancy and lactation that cyclin D1
appears to play a critical role. At the beginning of preg-
nancy, the mammary glands of Cyl-12/2 mice are able to
respond to estrogen and progesterone as evidenced by ex-
tensive side branching of the ducts (Fig. 1). Results from
studies of mice lacking estrogen and progesterone receptor
FIG. 4. Growth of transplanted mammary tissue in cleared mamm
ere taken from a recipient mouse at 17.5 days PC and prepared as w
xamination (bottom). Control transplant tissue (left) showing d
lobules when compared with mutant transplant tissue (right).Copyright © 1999 by Academic Press. All rightave shown that branching morphogenesis requires the
ombined action of estrogen and progesterone (Korach et
l., 1996; Lyndon et al., 1995). Extensive side branching of
he ducts still occurs in Cyl-12/2 mice, suggesting that early
estrogen- and progesterone-dependent processes are essen-
tially intact. This observation is supported by readily de-
tectable levels of progesterone receptor in the mammary
glands of Cyl-12/2 mice (Fig. 5A). Moreover, as the mito-
genic action of estrogen on mammary epithelial cells is
thought to be a paracrine response from the stroma, the
induction of progesterone receptor by estrogen suggests that
the mutant epithelial cells are responsive to stromal cues
(Cunha et al., 1997). However, the Cyl-12/2 mammary
issue showed a higher level of the B isoform of the
rogesterone receptor compared to controls. Recently, it
as shown that deliberate overexpression of the A isoform
t pads. Mammary glands containing transplanted mammary tissue
e mounts (top), which were subsequently processed for histological
r lobuloalveolar growth and increased accumulation of milk fatary fa
hol
enses of reproduction in any form reserved.
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n
8 Fantl et al.in the mammary epithelium disrupts its normal growth,
resulting in ductal thickening and more extensive lateral
branching (Shyamala et al., 1998). Thus, in mammary
FIG. 5. Progesterone receptor and Stat5a analysis in mammary gl
he stages indicated of progesterone receptor showing the A and B i
Cyl-12/1 mice (2 and 1, respectively). (B) Immunoprecipitation of S
phosphorylated (top) and total Stat5a protein (bottom) in Cyl-12/2
FIG. 6. Northern analysis of Stat5a and b-casein in mammary gla
bottom) in Cyl-12/2 mice and Cyl-12/1 mice (2 and 1, respectively
ormalized to keratin 19 (top).Copyright © 1999 by Academic Press. All righttissue from Cyl-12/2 mice, the lower level of A than of the
B isoform of PR might account for the delayed lobuloalveo-
lar growth, which is evident as smoother lateral branches in
from pregnant and 1 day postpartum mice. (A) Immunoblotting at
ms (PR-A and PR-B; 90 and 120 kDa, respectively) in Cyl-12/2 and
a and subsequent immunoblotting showing levels of both tyrosine
yl-12/1 mice.
RNA levels at the stages indicated of Stat5a (center) and b-casein
mbers under the panels refer to quantitation by phosphorimagingands
sofor
tat5
and Cnds.
). Nus of reproduction in any form reserved.
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9Mammary Gland Defect in Cyl-12/2 Mice Is Cell Autonomousearly pregnancy (Fig. 1). However, it would seem that cyclin
D1 is not essential for the dichotomous and lateral branch-
ing. Similarly, its postulated role as a coactivator for estro-
gen receptor would also appear not to be crucial for this
aspect of mammary gland development (Daniel et al., 1987;
Korach et al., 1996).
From early pregnancy, Cyl-12/2 mice show impaired lobu-
oalveolar growth (Figs. 1 and 2), although the severity of
he phenotype can differ significantly from mouse to
ouse. This abnormality coupled with the slower growth
ate of neonatal Cyl-12/2 mice raised the possibility that
both defects could reflect malfunctioning of the anterior
pituitary gland. It is in this tissue where prolactin and
growth hormone are synthesized by two discrete subsets of
cells arising from a single mammosomatotroph precursor.
Since a major role of prolactin in the mammary gland is to
stimulate lactogenesis, as well as to contribute to lobuloal-
veolar growth, low levels of prolactin would be consistent
with the observed mammary gland abnormalities (Vonder-
haar, 1987). An analogous situation has been observed in
female mice carrying only one allele of the prolactin recep-
tor. These mice show an impaired growth and lactogenic
response of the mammary gland, demonstrating the impor-
tance of the intensity of the prolactin signal during preg-
nancy (Ormandy et al., 1997). However, these mice also
showed an improved ability to suckle their young when the
age at first pregnancy was delayed and also with an increas-
ing number of pregnancies. This is not the case in the
present study where mice fail to nurture their young even
after multiple pregnancies and, moreover, where the abnor-
mality could not be linked to aberrant prolactin synthesis
or secretion (Fig. 3).
Results of the mammary gland transplantation experi-
ments further weaken the case for hormonal insufficiency
contributing to the phenotype and favor a cell autonomous
effect. Thus even when tissue containing mutant epithe-
lium is transplanted into a wild-type mammary fat pad and
FIG. 7. Milk caseins and WAP protein analyses in mammary g
showing levels of caseins and WAP as indicated in Cyl-12/2 (2) and
ass of milk proteins: a-casein, 35.6 kDa; b-casein, 25.3 kDa; whCopyright © 1999 by Academic Press. All rights exposed to a normal hormonal milieu, the resulting
ammary tree displays an aberrant phenotype. A similar
npublished result has been reported by C. Brisken and
. A. Weinberg (cited in Sicinski and Weinberg, 1997).
xperiments to test the functional integrity of the trans-
enic mammary gland fat pad by transplanting it with
issue containing normal epithelium could not be carried
ut as the transgenic animals had not been bred onto a
table genetic background. Since we were able to reproduce
he phenotype in a normal fat pad, it is unlikely that the
utant fat pad contributes to the mammary gland abnor-
ality to any significant extent. Interestingly, transplanta-
ion experiments using mammary epithelium that is
/EBPb-deficient also show impaired mammopoiesis and
efective lactogenesis similar to Cyl-12/2 and progesterone
receptor-deficient mice, suggesting that C/EBPb may play a
role in the regulation of these genes (Fantl et al., 1995;
Lyndon et al., 1995; Robinson et al., 1998; Seagroves et al.,
998; Sicinski et al., 1995).
The binding of prolactin to its cell surface receptor leads
o the subsequent phosphorylation and hence activation of
tat5a (Liu et al., 1995, 1997; Wakao et al., 1994). This
idely expressed transcriptional activator binds to GAS
interferon-g-activation site) elements present in the pro-
oters of many genes including those of several milk
rotein genes such as the caseins and WAP, and it has
roved to be important in the differentiation of alveolar
ells to a secretory phenotype (Li and Rosen, 1994; Robin-
on et al., 1995). Mice lacking Stat5a show reduced lobu-
oalveolar growth and fail to lactate after parturition, con-
rming the crucial role of this factor in lactogenesis (Liu et
l., 1997; Teglund et al., 1998). Analysis of Stat5a protein in
the mammary gland of both control and cyclin D1-deficient
mice showed an increase in levels with progression of
pregnancy, although after 11.5 days pc for a given stage of
pregnancy, the extracts from Cyl-12/2 mammary glands
contained less Stat5a protein than the control counterparts.
from pregnant and postpartum mice. Immunoblotting analysis
12/1 (1) mammary gland lysates at the stages indicated. (Molecular
idic protein, 14.9 kDa).lands
Cyl-
ey acs of reproduction in any form reserved.
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10 Fantl et al.However, of more functional importance is the level of
activation of the Stat5a protein (Gouilleux et al., 1994). For
mammary glands lacking cyclin D1 and demonstrating poor
morphological development, low levels of phosphorylated
Stat5a were seen in late pregnant and postpartum mice (Fig.
6). However, mammary glands with moderately impaired
growth showed reduced but readily detectable levels of
phosphorylated Stat5a. Consistent with the role of Stat5a in
the transcription of milk protein genes, a lower level of
Stat5a activation correlated with a greater delay in the
appearance of a- and b-caseins as well as a reduction in their
abundance in Cyl-12/2 mammary glands. A similar situa-
tion was observed for WAP, which is normally induced late
in pregnancy. This marker protein was not detected in
Cyl-12/2 mammary glands although by 1 day postpartum it
was found in some samples (Fig. 7).
In summary, in Cyl-12/2 mice there is a progressive
retardation of lobuloalveolar development and cell differen-
tiation during pregnancy that is intrinsic to the epithelial
cells. A possible explanation of this phenotype would be a
lengthening of the cell division time in the mammary
epithelium. This would be consistent with cell culture
studies that have shown that elevated cyclin D1 levels
shorten G1; therefore it is reasonable to expect that loss of
cyclin D1 would lengthen G1 (Quelle et al., 1993;
Resnitzky and Reed, 1995). The greater dependence of
mammary epithelium on cyclin D1 for its normal function-
ing when compared to other tissues and organs suggests a
lack of adequate compensatory mechanisms, a view sup-
ported by recent in situ hybridization studies that have
hown high levels of cyclin D1 in this cell lineage but very
ow levels of the other D-type cyclins (Sicinski and Wein-
erg, 1997). The reduced proliferative capacity would be
articularly important for a tissue that needs to grow
apidly within a restricted period of time. It would then
ollow that the delayed program of proliferation and differ-
ntiation driven primarily by ovarian hormones and also
ubsequently by placental hormones would be abruptly
erminated at parturition when the levels of many of these
ormones rapidly decline, trapping the gland in an under-
eveloped state.
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